Cytosorbents Corporation
- CTSO
- NASDAQ
- Medical devices
- Blood Purification Devices
- Extracorporeal Therapy
$4.96
Today +20.68%Quote Oct 19, 2026, 08:00 PM UTC
−13.74%over the last month
Max drawdown −46.8%From 1-month high −13.7%3 months −37.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Cytosorbents
Cytosorbents Corporation specializes in creating and bringing to market innovative medical devices. Their core expertise lies in a unique blood purification platform, built upon a proprietary adsorbent and porous polymer technology.
Where the money comes from
Q3 2024 revenue $8.6M
- Grant income$777,5939.0%
- Other sales$26,5210.3%
- Other / not reported$7.8M90.7%
Sector
Healthcare
Industry
Medical devices
Exchange
NASDAQ
Employees
129
Market value
$311.7M
Quote Oct 19
Floor
$4.86
2.0% below price
Resistance
$5.61
13.1% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CTSOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free